Contact

All Stories

  1. Thyroxine Replacement Therapy during Ramadan Fasting: A Narrative Review

    Article • Journal of Diabetes and Endocrine Practice, September 2024, Thieme Publishing Group

    Dr. Tamer M. Elsherbiny

  2. A survey on the management practices of graves’ disease by Egyptian physicians and a comparison to similar reports from USA, Italy, China, and Brazil

    Article • The Egyptian Journal of Internal Medicine, June 2024, Springer Science + Business Media

    Dr. Tamer M. Elsherbiny

  3. Real-world derived weight-based levothyroxine doses to achieve optimal thyrotropin target in different degrees of autoimmune hypothyroidism

    Article • The Egyptian Journal of Internal Medicine, April 2024, Springer Science + Business Media

    Dr. Tamer M. Elsherbiny

  4. Quitting smoking as a probable trigger for new-onset hypothyroidism after successful medical treatment of Graves’ disease: case report

    Article • Therapeutic Advances in Endocrinology and Metabolism, January 2024, SAGE Publications

    Dr. Tamer M. Elsherbiny

  5. Twice or thrice weekly levothyroxine provides similar rates of adherence and post-Ramadan euthyroidism compared to daily levothyroxine during Ramadan fasting

    Article • Thyroid Research, December 2023, Springer Science + Business Media

    Dr. Tamer M. Elsherbiny

  6. Abstract #1602340: Hashitoxicosis: A Retrospective Study of 44 Adult Patients

    Article • Endocrine Practice, December 2023, Elsevier

    Dr. Tamer M. Elsherbiny

  7. Abstract #1604667: Weight-Based Levothyroxine Dose to Achieve Optimal Thyrotropin Target in Subclinical Autoimmune Hypothyroidism

    Article • Endocrine Practice, December 2023, Elsevier

    Dr. Tamer M. Elsherbiny

  8. Abstract #1607909: Graves’ Disease Real-World Clinical Practices Survey From Egypt by Alexandria Thyroid Association

    Article • Endocrine Practice, December 2023, Elsevier

    Dr. Tamer M. Elsherbiny

  9. Characterization, treatment preferences, and outcomes of 390 Egyptian Graves’ disease patients: a retrospective study

    Article • The Egyptian Journal of Internal Medicine, August 2023, Springer Science + Business Media

    Dr. Tamer M. Elsherbiny

  10. Hypovitaminosis D masking hypercalcemia in primary hyperparathyroidism: case report

    Article • Therapeutic Advances in Endocrinology and Metabolism, January 2023, SAGE Publications

    Dr. Tamer M. Elsherbiny

  11. Abstract #1309273: Graves’ Disease in Egypt: A Study of 209 Patients

    Article • Endocrine Practice, December 2022, Elsevier

    Dr. Tamer M. Elsherbiny

  12. Abstract #1309357: Twice or Thrice Weekly Levothyroxine in Hypothyroid Patients Fasting During Ramadan

    Article • Endocrine Practice, December 2022, Elsevier

    Dr. Tamer M. Elsherbiny

  13. Abstract #1311147: Spontaneous Persistent Hypothyroidism After Medical Treatment for Graves’ Disease: A Series of 4 Cases

    Article • Endocrine Practice, December 2022, Elsevier

    Dr. Tamer M. Elsherbiny

  14. Impact of fasting on thyrotropin and thyroid status during Ramadan in 292 previously well controlled hypothyroid patients. IFTAR study

    Article • Endocrine, November 2022, Springer Science + Business Media

    Dr. Tamer M. Elsherbiny

  15. Twice or thrice weekly versus daily thyroxine in hypothyroid fasting ramadan: A pilot study

    Article • Indian Journal of Endocrinology and Metabolism, January 2022, Medknow

    Dr. Tamer M. Elsherbiny

  16. Preference, Adherence, and Maintenance of Euthyroidism Using 3 Different Regimens of Levothyroxine Intake during the Fasting Month of Ramadan

    Article • Dubai Diabetes and Endocrinology Journal, January 2021, Karger Publishers

    Dr. Tamer M. Elsherbiny

  17. Characterization of abnormal sleep patterns in patients with obesity, type 2 diabetes, or combined

    Article • Alexandria Journal of Medicine, December 2018, Taylor & Francis

    Dr. Tamer M. Elsherbiny

  18. Parathormone (PTH) is strongly related to left ventricular mass index (LVMI) in hypertensives, obese, and normal control

    Article • Alexandria Journal of Medicine, December 2018, Taylor & Francis

    Dr. Tamer M. Elsherbiny

  19. Inflammatory bowel disease severity and activity are correlated to thyroid gland nodularity, chronic nonthyroidal illness, and thyroid autoantibodies but not thyroid dysfunction

    Article • Egyptian Journal of Obesity Diabetes and Endocrinology, January 2016, Medknow

    Dr. Tamer M. Elsherbiny

  20. The potential of serum copeptin as a prognostic marker of mortality in patients with sepsis, severe sepsis, or septic shock

    Article • Egyptian Journal of Obesity Diabetes and Endocrinology, January 2016, Medknow

    Dr. Tamer M. Elsherbiny

  21. Influence of thyroid function on the outcome of percutaneous coronary intervention in euthyroid patients with coronary artery disease

    Article • Egyptian Journal of Obesity Diabetes and Endocrinology, January 2015, Medknow

    Dr. Tamer M. Elsherbiny

  22. Hashimoto thyroiditis is an independent cardiovascular risk factor in clinically hypothyroid patients

    Article • Alexandria Journal of Medicine, December 2011, Elsevier

    Dr. Tamer M. Elsherbiny